[Indications for urgent coronary angiography. Part II: Acute coronary syndromes without ST-segment elevation]

Area of Science:

• Cardiology
• Internal Medicine
• Clinical Practice Guidelines

Background:

• The optimal treatment for acute coronary syndrome without ST elevation (NSTEMI) remains debated.
• Current literature does not support a universal invasive strategy for all NSTEMI patients.
• Risk stratification is crucial for tailoring treatment decisions.

Purpose of the Study:

• To evaluate the efficacy of different therapeutic approaches for NSTEMI.
• To determine the role of invasive strategies based on patient risk.
• To provide guidance on optimal medical management and intervention timing.

Main Methods:

• Review of existing literature and clinical trial data on NSTEMI management.
• Analysis of outcomes comparing invasive versus conservative strategies.
• Emphasis on patient risk stratification using established clinical criteria.

Main Results:

• Low-risk NSTEMI patients do not demonstrate significant benefit from an invasive strategy compared to conservative medical treatment.
• High-risk NSTEMI patients have shown to benefit from an invasive approach.
• Persistent or recurrent ischemic symptoms under optimal medical treatment warrant urgent coronary angiography.

Conclusions:

• Individualized risk assessment is paramount in NSTEMI management.
• An invasive strategy should be reserved for high-risk NSTEMI patients.
• Urgent angiography is indicated for refractory ischemic symptoms despite medical therapy.